Lotus Bio-Technology Company Top Management

LBTD Stock  USD 0.01  0.00  0.00%   
Lotus Bio-Technology employs about 4 people. The company is managed by 2 executives with a total tenure of roughly 7 years, averaging almost 3.0 years of service per executive, having 2.0 employees per reported executive. Evaluation of Lotus Bio-Technology's management performance can provide insight into the firm performance.
Zoltan Nagy  CEO
President CEO, Director
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lotus Bio Technology Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty.

Lotus Bio-Technology Management Team Effectiveness

The company has return on total asset (ROA) of (4.213) % which means that it has lost $4.213 on every $100 spent on assets. This is way below average. Lotus Bio-Technology's management efficiency ratios could be used to measure how well Lotus Bio-Technology manages its routine affairs as well as how well it operates its assets and liabilities.
Lotus Bio Technology maintains a total of 782.77 Million outstanding shares. Lotus Bio Technology Development secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.4 % of Lotus Bio Technology Development outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Lotus Bio-Technology in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Lotus Bio-Technology, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Lotus Bio-Technology Workforce Comparison

Lotus Bio Technology Development is currently regarded as number one stock in number of employees category among its peers. The total workforce of Consumer Discretionary industry is now estimated at about 305. Lotus Bio-Technology claims roughly 4.0 in number of employees contributing just under 2% to stocks in Consumer Discretionary industry.

Lotus Bio Technology Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Lotus Bio Technology Price Series Summation is a cross summation of Lotus Bio-Technology price series and its benchmark/peer.

Lotus Bio-Technology Notable Stakeholders

A Lotus Bio-Technology stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Lotus Bio-Technology often face trade-offs trying to please all of them. Lotus Bio-Technology's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Lotus Bio-Technology's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Zoltan NagyPresident CEO, DirectorProfile
Hoyt ChristopherChief OfficerProfile
String symbol = request.getParameter("s");

About Lotus Bio-Technology Management Performance

The success or failure of an entity such as Lotus Bio Technology often depends on how effective the management is. Lotus Bio-Technology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Lotus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Lotus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona. Lotus Bio-Technology is traded on OTC Exchange in the United States.
Please note, the presentation of Lotus Bio-Technology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lotus Bio-Technology's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Lotus Bio-Technology's management manipulating its earnings.

Lotus Bio-Technology Workforce Analysis

Traditionally, organizations such as Lotus Bio-Technology use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Lotus Bio-Technology within its industry.

Lotus Bio-Technology Manpower Efficiency

Return on Lotus Bio-Technology Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee4.9K
Net Loss Per Executive9.8K

Complementary Tools for Lotus Pink Sheet analysis

When running Lotus Bio-Technology's price analysis, check to measure Lotus Bio-Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Bio-Technology is operating at the current time. Most of Lotus Bio-Technology's value examination focuses on studying past and present price action to predict the probability of Lotus Bio-Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Bio-Technology's price. Additionally, you may evaluate how the addition of Lotus Bio-Technology to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing